Mannucci, Edoardo, et al. “Clinical and Economic Rationale for the Early Use of SGLT2 Inhibitors in Patients With Type 2 Diabetes”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 21, no. 1S, Dec. 2020, doi:10.7175/fe.v21i1S.1490.